2 "Magnificent Seven" Stocks Billionaires Are Buying
Billionaire investors generally choose stocks of profitable companies that can safely preserve and grow their capital over the long term. This is naturally leading many top investors to invest in the ...
Stocks Give Up Gains As Tariffs Loom—Nvidia’s DeepSeek Selloff Balloons Back To $500 Billion
Leading the swing were Apple and Nvidia, both Silicon Valley giants with significant dealings in China, as shares of Apple ...
Is Meta Platforms, Inc. (META) the Best Stock for Beginners With Little Money?
We recently compiled a list of the 10 Best Stocks for Beginners with Little Money According to Hedge Funds. In this article, we are going to take a look at where Meta Platforms, Inc.
Meta CEO Mark Zuckerberg Just Shared Great News for Nvidia, Broadcom, and Arista Networks Investors
Meta's artificial intelligence plans will break new ground in 2025.
Meta Platforms Stock Analysis: Buy, Hold, or Sell?
Meta Platforms (NASDAQ: META) reported quarterly financial results demonstrating continued growth in all the key segments. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every ...
Jim Cramer On If Meta Platforms, Inc (META) Was Going Into The Quarter Too Hot: ‘Uh, Too Hot? Taekwondo, No’
We recently published an article titled Jim Cramer Discusses These 10 Stocks & Says He’s In Waiting For AI GPU Spending Clarity. In this article, we are going to take a look at where Meta Platforms, ...
Wall Street dragged lower at close by Trump's plan to enact tariffs on Saturday.
U.S. stocks fall on Friday after the White House says Canada, Mexico and China tariffs will start Saturday. Still, major indexes finish January ahead.
US High School Economics class: Tech stocks slump as China’s DeepSeek stokes fears over AI spending
Essential Question: How does DeepSeek’s rise as an AI competitor challenge global tech dominance, and what does it reveal about the economic forces driving innovation, competition, and market ...
thesmartinvestor21h
Top Stock Market Highlights of the Week: China’s DeepSeek, DBS Group and Mapletree Investments
We delve into the latest artificial intelligence program developed by China and look at acquisitions conducted by a reputable ...
Metsera hits $2.7 bln valuation as shares surge 42% in Nasdaq debut
Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...
U.S. Money Supply Recently Did Something Last Seen During the Great Depression -- and It's Historically a Precursor to a Big Move in Stocks
Based on what 155 years of historic precedent tells us about notable declines in M2 and the performance of the U.S. economy ...
Maze Therapeutics valued at $690.4 million in lukewarm Nasdaq debut
Maze Therapeutics became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a valuation of $690.37 million.